Literature DB >> 20088380

[Association of the C1858T polymorphism of the PTPN22 gene with type 1 diabetes].

E Iu Lavrikova, A G Nikitin, Iu A Seregin, L I Zil'berman, N M Tsitlidze, T L Kuraeva, V A Peterkova, I I Dedov, V V Nosikov.   

Abstract

To study the association with diabetes mellitus type 1 (T1DM) we performed TDT analysis and analysis of the distribution of frequencies of alleles and genotypes of polymorphic marker C1858T of the PTPN22 gene, encoding tyrosine phosphatase of non-receptor type (LYP). Groups of concordant (27 families) and discordant (62 families) sibpairs and groups of T1DM patients and unrelated controls of Russian origin were recruited in Endocrinology Research Center, Moscow and Center of Diabetes, Samara. For a given polymorphic marker was not found statistically significant associations with type 1 diabetes in the transmission disequilibrium test, while analysis of the distribution of frequencies of alleles and genotypes showed the association with T1DM. Thus, the polymorphic marker C1858T of the PTPN22 gene is associated with T1DM in Russian patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20088380

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  3 in total

1.  Meta-analysis of the family-based association between the PTPN22 C1858T polymorphism and type 1 diabetes.

Authors:  Young Ho Lee; Gwan Gyu Song
Journal:  Mol Biol Rep       Date:  2012-10-08       Impact factor: 2.316

2.  Improving power of genome-wide association studies with weighted false discovery rate control and prioritized subset analysis.

Authors:  Wan-Yu Lin; Wen-Chung Lee
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

Review 3.  The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis.

Authors:  Fang Dong; Guang Yang; Hong-Wei Pan; Wei-Huang Huang; Li-Peng Jing; Wen-Kai Liang; Na Zhang; Bao-Huan Zhang; Man Wang; Yang Liu; Li-Ju Zhang; Si-Heng Zhang; He Li; Chuan Chen; Li-Hong Nie; Chun-Xia Jing
Journal:  Acta Diabetol       Date:  2014-07-09       Impact factor: 4.280

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.